Search

Search bills, members, committees and pages...

B HALL STRATEGIES, LLC

110 federal lobbying filings, 2025 to 2026.

B HALL STRATEGIES, LLC is a registrant on 110 federal lobbying filings, 2025 to 2026, reporting $2.9M across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.


Clients

19 who it filed for, by filings.

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
202638$1.2M
202572$1.7M

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
PHAPharmacy52
MMMMedicare/Medicaid49
HCRHealth Issues20
BUDBudget/Appropriations1
MEDMedical/Disease Research/Clinical Labs1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 842Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act5
H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act4

Lobbyists

Named on the filings.

LobbyistClientsFilings
JAMES HALL19110

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMAB HALL STRATEGIES, LLC2026 second_quarter$50KJul 19, 2026
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTISB HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLCB HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.B HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANYB HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.B HALL STRATEGIES, LLC2026 second_quarter$50KJul 19, 2026
TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICAB HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.B HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATIONB HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP ON BEHALF OF ORGANON, LLCB HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC.B HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.B HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALSB HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.B HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.B HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.B HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.B HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP OBO SIEMENS HEALTHINEERSB HALL STRATEGIES, LLC2026 second_quarter$30KJul 19, 2026
TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCEB HALL STRATEGIES, LLC2026 second_quarterJul 19, 2026
TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCEB HALL STRATEGIES, LLC2026 second_quarterJul 16, 2026
TIBER CREEK GROUP OBO SIEMENS HEALTHINEERSB HALL STRATEGIES, LLC2026 first_quarter$30KApr 9, 2026
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.B HALL STRATEGIES, LLC2026 first_quarter$50KApr 9, 2026
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTISB HALL STRATEGIES, LLC2026 first_quarter$30KApr 9, 2026
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLCB HALL STRATEGIES, LLC2026 first_quarter$30KApr 9, 2026
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.B HALL STRATEGIES, LLC2026 first_quarter$30KApr 9, 2026